4th Annual MarketsandMarkets Single-Cell Omics Conference

WHAT TO EXPECT

Single cell genomic analysis for cancer/cellular heterogeneity
Single Cell Transcriptional Profiling, Digital spatial profiling
Spatial Single cell genome analysis – Sequencing application
Single-Cell phenotyping
Application of multiplex imaging – Single cell and tissue imaging
Current & Emerging Tools and Data Analysis in Single Cell Omics
Single Cell Analysis in Drug Discovery & Development – Sample Preparation and Processing
Microfluidics Tools for Single Cell Analysis
Cancer Biomarker discovery
Nanopore Technology – A Potential Application in Functional Genomics

Witness live action how Single-Cell Omics technology is revolutionizing the future of Biomedical research
Quality insights and cohesiveness of key issues with respect to Single-Cell to be addressed
Discover the different avenues in application of Multi-Omics studies
Comprehend the current and future research avenues of Single-Cell Omics in drug discovery and development
Discuss the emerging technologies and opportunities with cutting edge strategies
Opportunity for one-on-one networking with the delegates and extend professional competency

Industry: Pharma/Therapeutic Companies/Start Up’s
CEOs, CMO’s, CSO’s, COO’s, Presidents, Vice Presidents, Directors, Managing Directors, Head of Departments, Executive Leaders, Pharmacists, Oncologists, Geneticists, Bioinformatician, Protein Scientist, Principal Scientists, Big Data Scientists, Business Development, Regulatory and Policy Advisors, Diagnostic Laboratory Professionals, Global Leaders.
Departments: Genomics, Proteomics, Oncology, Molecular Biology, Genetics Bioinformatics, Computational Biology, Protein science, Pharmacogenomics, Biotechnology, Data Science, Microbiologists, Virologists, Pathologists
Academics: Universities, Research Institutes, Hospitals
Head of Departments, Professors, Lecturers, Senior Scientists, Researchers, Bioinformaticians
Departments: Genomics, Proteomics, Oncology, Molecular Biology, Genetics Bioinformatics, Computational Biology, Protein science, Pharmacogenomics, Biotechnology, Data science, Microbiologists, Virologists, Pathologists

CONFERENCE AGENDA

Registration	08:15 - 08:50
Welcome note by MarketsandMarkets	08:50 - 08:55
Opening remarks by the Chairperson Paloma Cejas, Head of Innovation, Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute	08:55 - 09:00
Novel Research in Single-Cell Omics Analysis
Enhancing Drug Discovery and Development with Single Cell Precision Pascaline Mary, Senior Director Head of Single Cell Science, HiFiBiO Therapeutics	09:00 - 09:30
Harnessing the Power of Single Cell Omics to Characterize Cancer Heterogeneity and Discover Novel Biomarkers Assieh Saadatpour, Associate Director, Johnson & Johnson	09:30 - 10:00
Exploring Spatial Multiomics Enabled by PhenoCycler-Fusion Aniruddh Solanki, Senior Manager Global Market Development, Akoya Biosciences	10:00 - 10:30
Morning Refreshments and Poster Presentation \| One-to-One Networking Meeting	10:30 - 11:20
Single-cell Multimodal Analysis for CART Therapies Priya S. Chockalingam, Vice President, Head of Clinical Bioanalytics & Translational Sciences, Beam Therapeutics	11:20 - 11:50
Driving Novel AAV Capsid Discovery Using Single Nuclei RNA Sequencing Arpan Ghosh, Senior Scientist, Dyno Therapeutics	11:50 - 12:20
Protein Quantification from a Single Cell Using TMTpro™ Mass Spectrometry Ian Pike, Chief Scientific Officer, Proteome Sciences PLC	12:20 - 12:50
Lunch \| One-to-One Networking Meetings	12:50 - 13:50
Exploring Intra Cardiac Nervous System using Single Cell Scale Omics Analysis Lakshmi Kuttippurathu, Associate Director, Computational Biology & Data Sciences, Lexicon Pharmaceuticals	13:50 - 14:20
Identification of Cancer Subtypes in Neuroendocrine Tumors by Single Cell Multiomics Henry Long, Scientific Director, Dana Farber Cancer Institute	14:20 - 14:50
Panel Discussion \| Utilizing Single Cell Omics in Clinical and Pre-Clinical Studies Asaf Rotem, Senior Director, Astrazeneca Paloma Cejas, Head of Innovation, Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute Priya S. Chockalingam, Vice President, Head of Clinical Bioanalytics & Translational Sciences, Beam Therapeutics Arpan Ghosh, Senior Scientist, Dyno Therapeutics Danny Bavli, Research Associate, Harvard University	14:50 - 15:30
Afternoon Refreshments \| One-to-One Networking Meetings	15:30 - 16:20
Assessing the Immune Response to Stem Cell-Derived Islets in Humanized Mice using Spatial Transcriptomics and Multiplex Imaging Danny Bavli, Research Associate, Harvard University	16:20 - 16:50
Cell-Type Specific Sample Preparation: Experimental Considerations and Enrichment Strategies David Gallegos, Scientist II, Takeda	16:50 - 17:20
Closing remarks by the Chairperson Paloma Cejas, Head of Innovation, Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute	17:20 - 17:20
END OF DAY 1 \| Drinks Reception and Networking	17:20 - 17:20

Registration	08:15 - 08:55
Welcome note by MarketsandMarkets	08:50 - 08:55
Opening Remarks by the Chairperson Paloma Cejas, Head of Innovation, Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute	08:55 - 09:00
Emerging tools and Technologies in Single Cell Omics
Integrating Single Cell Genomics into Clinical Studies Asaf Rotem, Senior Director, Astrazeneca	09:00 - 09:30
Impacts of Advanced Omic Technologies in Pharmaceutical Research & Development Tom Lanz, Director of Multi-Omics and Biomarkers, Pfizer	09:30 - 10:00
Single-Cell Technology in Cancer: A Tool for Novel Immunotherapy Targets Parveen Kumar, Senior Scientist, Boehringer Ingelheim	10:00 - 10:30
Morning Refreshments and Poster Presentation \| One-to-One Networking	10:30 - 11:20
Navigating the Bioinformatic Landscape of Single Cell Data Analysis David Gallegos, Scientist II, Takeda	11:20 - 11:50
Applications of Multi-Omics in Clinical Samples for Cancer Precision Medicine Paloma Cejas, Head of Innovation, Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute	11:50 - 12:20
Panel Discussion \| Gaps in Current Single Cell or Spatial Technologies Tom Lanz, Director of Multi-Omics and Biomarkers, Pfizer Ajay Nair, Associate Research Scientist, Columbia University in the City of New York Henry Long, Scientific Director, Dana Farber Cancer Institute David Gallegos, Scientist II, Takeda Parveen Kumar, Senior Scientist, Boehringer Ingelheim Joost Groot, Principal Consultant Computational Biology, Applied SysBio	12:20 - 13:00
Lunch and Poster Presentation \| One-to-One Networking	13:00 - 14:00
Single-cell Regulator Activity Inference Pipeline Identifies Master Regulators of Liver Fibrosis Ajay Nair, Associate Research Scientist, Columbia University in the City of New York	14:00 - 14:30
Closing remarks by the chairperson	14:30 - 14:30
End of Conference	14:30 - 14:30